PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
RVNC vs. URA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between RVNC and URA is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

RVNC vs. URA

Last updated Jun 1, 2025

Compare and contrast key facts about Revance Therapeutics, Inc. (RVNC) and Global X Uranium ETF (URA).

URA is a passively managed fund by Global X that tracks the performance of the Solactive Global Uranium & Nuclear Components Index. It was launched on Nov 4, 2010.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RVNC or URA.

Performance

RVNC vs. URA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revance Therapeutics, Inc. (RVNC) and Global X Uranium ETF (URA). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Returns By Period

RVNC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

URA

YTD

19.53%

1M

26.47%

6M

1.63%

1Y

2.06%

3Y*

17.03%

5Y*

27.70%

10Y*

6.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Revance Therapeutics, Inc.

Global X Uranium ETF

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

RVNC vs. URA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
RVNC
The Risk-Adjusted Performance Rank of RVNC is 4141
Overall Rank
The Sharpe Ratio Rank of RVNC is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of RVNC is 5050
Sortino Ratio Rank
The Omega Ratio Rank of RVNC is 5151
Omega Ratio Rank
The Calmar Ratio Rank of RVNC is 3131
Calmar Ratio Rank
The Martin Ratio Rank of RVNC is 3535
Martin Ratio Rank
URA
The Risk-Adjusted Performance Rank of URA is 1818
Overall Rank
The Sharpe Ratio Rank of URA is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of URA is 2121
Sortino Ratio Rank
The Omega Ratio Rank of URA is 2020
Omega Ratio Rank
The Calmar Ratio Rank of URA is 1616
Calmar Ratio Rank
The Martin Ratio Rank of URA is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RVNC vs. URA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Revance Therapeutics, Inc. (RVNC) and Global X Uranium ETF (URA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

RVNC vs. URA - Dividend Comparison

RVNC has not paid dividends to shareholders, while URA's dividend yield for the trailing twelve months is around 2.39%.

TTM20242023202220212020201920182017201620152014
RVNC
Revance Therapeutics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
URA
Global X Uranium ETF		2.39%2.86%6.07%0.76%5.85%1.69%1.66%0.45%2.03%7.28%1.96%4.28%

Drawdowns

RVNC vs. URA - Drawdown Comparison

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

RVNC vs. URA - Volatility Comparison

Loading data...